These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

799 related items for PubMed ID: 16126463

  • 1. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
    Feeley BT, Krenek L, Liu N, Hsu WK, Gamradt SC, Schwarz EM, Huard J, Lieberman JR.
    Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
    [Abstract] [Full Text] [Related]

  • 2. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT, Gamradt SC, Hsu WK, Liu N, Krenek L, Robbins P, Huard J, Lieberman JR.
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [Abstract] [Full Text] [Related]

  • 3. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
    Ye L, Lewis-Russell JM, Kynaston H, Jiang WG.
    J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
    [Abstract] [Full Text] [Related]

  • 4. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
    Dai J, Keller J, Zhang J, Lu Y, Yao Z, Keller ET.
    Cancer Res; 2005 Sep 15; 65(18):8274-85. PubMed ID: 16166304
    [Abstract] [Full Text] [Related]

  • 5. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M, Murai J, Yoshikawa H, Tsumaki N.
    J Bone Miner Res; 2006 Jul 15; 21(7):1022-33. PubMed ID: 16813523
    [Abstract] [Full Text] [Related]

  • 6. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer.
    Masuda H, Fukabori Y, Nakano K, Takezawa Y, CSuzuki T, Yamanaka H.
    Prostate; 2003 Mar 01; 54(4):268-74. PubMed ID: 12539225
    [Abstract] [Full Text] [Related]

  • 7. The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone.
    Gamradt SC, Feeley BT, Liu NQ, Roostaeian J, Lin YQ, Zhu LX, Sharma S, Dubinett SM, Lieberman JR.
    Anticancer Res; 2005 Mar 01; 25(1A):107-15. PubMed ID: 15816526
    [Abstract] [Full Text] [Related]

  • 8. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
    Armstrong AP, Miller RE, Jones JC, Zhang J, Keller ET, Dougall WC.
    Prostate; 2008 Jan 01; 68(1):92-104. PubMed ID: 18008334
    [Abstract] [Full Text] [Related]

  • 9. Regarding the article "Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions", by Feeley et al.
    Friedlaender GE.
    Bone; 2006 Sep 01; 39(3):666; author reply 667. PubMed ID: 16774855
    [No Abstract] [Full Text] [Related]

  • 10. Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration.
    Feeley BT, Liu NQ, Conduah AH, Krenek L, Roth K, Dougall WC, Huard J, Dubinett S, Lieberman JR.
    J Bone Miner Res; 2006 Oct 01; 21(10):1571-80. PubMed ID: 16995812
    [Abstract] [Full Text] [Related]

  • 11. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
    Lai TH, Fong YC, Fu WM, Yang RS, Tang CH.
    Prostate; 2008 Sep 01; 68(12):1341-53. PubMed ID: 18512729
    [Abstract] [Full Text] [Related]

  • 12. Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.
    Schwaninger R, Rentsch CA, Wetterwald A, van der Horst G, van Bezooijen RL, van der Pluijm G, Löwik CW, Ackermann K, Pyerin W, Hamdy FC, Thalmann GN, Cecchini MG.
    Am J Pathol; 2007 Jan 01; 170(1):160-75. PubMed ID: 17200191
    [Abstract] [Full Text] [Related]

  • 13. Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone.
    Virk MS, Petrigliano FA, Liu NQ, Chatziioannou AF, Stout D, Kang CO, Dougall WC, Lieberman JR.
    Bone; 2009 Jan 01; 44(1):160-7. PubMed ID: 18929692
    [Abstract] [Full Text] [Related]

  • 14. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.
    Ye L, Kynaston H, Jiang WG.
    Mol Cancer Res; 2008 Oct 01; 6(10):1594-606. PubMed ID: 18922975
    [Abstract] [Full Text] [Related]

  • 15. Bone morphogenetic protein signaling in prostate cancer cell lines.
    Brubaker KD, Corey E, Brown LG, Vessella RL.
    J Cell Biochem; 2004 Jan 01; 91(1):151-60. PubMed ID: 14689587
    [Abstract] [Full Text] [Related]

  • 16. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells.
    Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J.
    Carcinogenesis; 2003 Sep 01; 24(9):1445-54. PubMed ID: 12819188
    [Abstract] [Full Text] [Related]

  • 17. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F, Lee J, Lu S, Pettaway CA, Dong Z.
    Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637
    [Abstract] [Full Text] [Related]

  • 18. The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.
    Miwa S, Mizokami A, Keller ET, Taichman R, Zhang J, Namiki M.
    Cancer Res; 2005 Oct 01; 65(19):8818-25. PubMed ID: 16204052
    [Abstract] [Full Text] [Related]

  • 19. Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer.
    Haudenschild DR, Palmer SM, Moseley TA, You Z, Reddi AH.
    Cancer Res; 2004 Nov 15; 64(22):8276-84. PubMed ID: 15548695
    [Abstract] [Full Text] [Related]

  • 20. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML.
    Cancer Res; 1999 Apr 15; 59(8):1987-93. PubMed ID: 10213511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.